Bioscience News - GEG Tech top picks
8.8K views | +2 today
Follow
Bioscience News - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection - Nature Communication

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection - Nature Communication | Bioscience News - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

A team of French researchers has come up with an anti-Covid solution which is an alternative to a vaccination and which could be ready for use  in the form of a nasal spray. They have created a peptide, made up of natural amino acids which lures the virus to it by mimicking the ACE2 lock, and so prevents it from entering into human cells. They have tested it on pulmonary cells and found it has worked without any toxic reaction to humans. These first-in-class blocking peptide mimics represent powerful tools that might be used in prophylactic and therapeutic approaches to fight the coronavirus disease 2019.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-c...

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-c... | Bioscience News - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year. The findings are from the first trial of filovirus vaccines in Africa.


www.geg-tech.com

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies | Bioscience News - GEG Tech top picks | Scoop.it
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke.
BigField GEG Tech's insight:

AstraZeneca shares turned negative Wednesday after a Brazilian health authority said a volunteer in its coronavirus vaccine study died.

The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

No comment yet.